Prevalence of Prostate Cancer Clinical States and Mortality in the United States: Estimates Using a Dynamic Progression Model

@inproceedings{Scher2015PrevalenceOP,
  title={Prevalence of Prostate Cancer Clinical States and Mortality in the United States: Estimates Using a Dynamic Progression Model},
  author={Howard I. Scher and Kirk Solo and Jason Valant and Mary Beth Todd and Maneesha Mehra and St{\'e}phanie Filleur},
  booktitle={PloS one},
  year={2015}
}
OBJECTIVE To identify patient populations most in need of treatment across the prostate cancer disease continuum, we developed a novel dynamic transition model based on risk of disease progression and mortality. DESIGN AND OUTCOME MEASUREMENTS We modeled the flow of patient populations through eight prostate cancer clinical states (PCCS) that are characterized by the status of the primary tumor, presence of metastases, prior and current treatment, and testosterone levels. Simulations used… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 19 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 25 REFERENCES

NCCN clinical guidelines in oncology—prostate cancer

  • JL Mohler, AJ Armstrong, RR Bahnson, B Boston, JE Busby, AV D'Amico
  • Version I.. National Comprehensive Cancer Network…
  • 2015
Highly Influential
4 Excerpts

Similar Papers

Loading similar papers…